Understand what your gut health results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
Bacteroides cellulosilyticus: A cellulose-degrading specialist
The Bacteroides cellulosilyticus test analyzes DNA from a small stool sample to quantify the relative abundance of Bacteroides cellulosilyticus, a fiber‑degrading gut bacterium that thrives on complex plant carbohydrates. Depending on the lab, measurement is done with shotgun metagenomic sequencing or targeted assays (such as qPCR) that resolve species‑level signals; some 16S rRNA methods cannot reliably distinguish this species from close relatives, which is noted in the report as a limitation. Results reflect a current snapshot of your gut ecosystem rather than a fixed trait. Collection is simple at home, and the lab reports your percentage or copies per gram alongside a reference range derived from healthy populations.
Why this matters: B. cellulosilyticus specializes in digesting cellulose and other complex fibers using polysaccharide utilization loci (PULs)—think of them as molecular toolkits for unlocking calories from plants. As it ferments fibers, it helps generate short‑chain fatty acids (SCFAs) such as acetate and propionate, which support gut barrier integrity, immune signaling, and cross‑feeding of other microbes that produce butyrate. In practical terms, this species contributes to smoother digestion, more efficient energy harvest from plants, and steady inflammatory tone, though individual responses vary and the science continues to evolve.
Why this particular fiber shredder matters
Your gut is a bustling ecosystem where different species share the workload. B. cellulosilyticus is one of the cellulose “shredders,” helping convert tough plant fibers into SCFAs that your body can use. Testing can reveal whether your gut has enough of this capability on board or if there’s an imbalance. That information may help explain why a high‑salad day leaves you gassy, why a low‑fiber phase coincides with sluggishness, or how a recent antibiotic course affected your plant‑fiber processing. It can also clarify the impact of lifestyle shifts—like moving toward a plant‑forward diet, cutting carbs for a training block, or changing appetite and meal size during a weight‑loss program—on your fiber‑fermenting capacity.
Zooming out, your microbiome influences digestion, metabolic flexibility, inflammation, and even how you feel after meals. Regularly checking a few “anchor” organisms, including B. cellulosilyticus, helps you see patterns over time: greater diversity with more varied plants, or dips after illness and rebound with recovery. The goal isn’t a perfect number but pattern recognition—using objective data to understand how your gut adapts and to guide preventive care and long‑term wellness with your clinician.
Making sense of the number
Results are typically reported as a relative abundance (the percentage of all microbial DNA) or as an absolute measure (gene copies per gram), compared to a reference population. “Balanced” levels suggest your gut has the tools to handle complex carbohydrates from foods like leafy greens, legumes, whole grains, and nuts. Because microbiomes are highly individual, there is no single “ideal” number—context matters, including your diet, geography, and age.
When B. cellulosilyticus is present within a healthy range, that usually maps to efficient fiber fermentation, good SCFA output, and a steadier gut barrier. Cross‑feeding also comes into play: acetate and propionate produced by Bacteroides can be used by other bacteria to generate butyrate, which is closely tied to colon lining health. In this state, people often notice less post‑meal heaviness with high‑fiber meals and more predictable regularity.
If B. cellulosilyticus is low or undetectable, it may indicate reduced capacity to process certain plant fibers. That can show up as fiber intolerance, more gas with raw vegetables, or feeling “overfull” after salads. Very high levels, especially alongside low overall diversity, may reflect a microbiome leaning heavily on a few species—sometimes seen after restrictive diets or recent antibiotics—and can coincide with variable stool consistency. These findings are not diagnoses; they highlight functional patterns worth exploring with your care team and, if symptoms persist, may prompt broader evaluation.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Markers that round out the story
For the clearest picture, interpret this result alongside other data: overall microbial diversity; presence of beneficial genera (such as Bifidobacterium and Faecalibacterium); and gut‑related markers like fecal calprotectin (inflammation) or fecal elastase (pancreatic digestion) when clinically indicated. Practical realities matter, too. Day‑to‑day variation is normal; stool testing mostly samples luminal (not mucosal) microbes; and methods differ across labs. Species‑level calls are most reliable with metagenomic sequencing or validated targeted assays, while 16S can under‑ or misclassify closely related Bacteroides. Life stage and context also shape interpretation—microbiomes naturally vary with aging, pregnancy, travel, and major diet changes—so trends over time are often more meaningful than a single snapshot.
Frequently Asked Questions
References
- El Kaoutari A, Armougom F, Gordon JI, Raoult D, Henrissat B (2013). The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. *Nature Reviews Microbiology*, *11*(7), 497-504. https://doi.org/10.1038/nrmicro3050
- Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. *Cell*, *165*(6), 1332-1345. https://doi.org/10.1016/j.cell.2016.05.041
- Durazzi F, Sala C, Castellani G, Manfreda G, Remondini D, De Cesare A (2021). Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. *Scientific Reports*, *11*, 3030. https://doi.org/10.1038/s41598-021-82726-y
- Lynch SV, Pedersen O (2016). The human intestinal microbiome in health and disease. *The New England Journal of Medicine*, *375*(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
- Porcari S, Mullish BH, Asnicar F, Ng SC, Zhao L, Hansen R, O'Toole PW, Raes J, Hold G, Putignani L, Gasbarrini A, Segata N, Cammarota G (2025). International consensus statement on microbiome testing in clinical practice. *The Lancet Gastroenterology & Hepatology*, *10*(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X
